JWM
ZOM

Jackson Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Jackson Wealth Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-639,510
Closed -$76K – 122
2026
Q1 		$76K Hold
639,510
– – 0.01% 142
2025
Q4 		$65K Hold
639,510
– – 0.01% 142
2025
Q3 		$50K Buy
+639,510
New +$50K 0.01% 155
2025
Q2 		– Sell
-142,857
Closed -$8K – 174
2025
Q1 		$8K Hold
142,857
– – ﹤0.01% 166
2024
Q4 		$17K Hold
142,857
– – ﹤0.01% 160
2024
Q3 		$20K Buy
+142,857
New +$20K ﹤0.01% 157

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $378M AUM 18.32% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Jackson Wealth Management's ZOM Position: Q2 2026 in Review

Jackson Wealth Management sold out of Zomedica Corp. (ZOM) in Q2 2026, closing a stake of 639,510 shares — an estimated $76K sold.

Jackson Wealth Management first reported a position in ZOM in Q3 2024 and held it in 6 quarters. The position peaked at $76K in Q1 2026. 7 funds tracked by Wall St. Rank hold ZOM as of Q2 2026.

  • Jackson Wealth Management reported no remaining Zomedica Corp. position as of Q2 2026 after selling out during the quarter.
  • Jackson Wealth Management sold 639,510 Zomedica Corp. shares in Q2 2026, an estimated $76K.
  • Jackson Wealth Management first reported a position in Zomedica Corp. in Q3 2024 and held it in 6 quarters.
  • Jackson Wealth Management's Zomedica Corp. position peaked at $76K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2026.

Based on Jackson Wealth Management's 13F filing for Q2 2026, filed 20 Aug 2026.